Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

SenseTime Unveils the “AI Ethics for Balanced Development” Report and “Best Practice Cases” to Reinforce Positive Progress in Sustainable and Ethical Development of AI

Published

2 years ago

on

 

SenseTime, a leading global artificial intelligence (AI) software company, today released the “AI Sustainable Development Report 2021-2022: AI Ethics for Balanced Development” and its “Best Practice Cases”. Launched in conjunction with SFF (Singapore FinTech Festival) x SWITCH in Singapore, the two assets reinforce SenseTime’s positive progress towards its long-term goal of contributing towards the sustainable and ethical development of AI.

The “AI Ethics for Balanced Development” report follows SenseTime’s “Code of Ethics for AI Sustainable Development” whitepaper, which was published in June 2020, to further crystalize SenseTime’s three core ethical principles of responsible AI: sustainability, human-centric approach, and controllable technology. In addition to this, the “Best Practice Cases” is the first set of case studies in the market to document positive developments in the ever-evolving AI industry.

Releasing the “AI Ethics for Balanced Development” report and “Best Practice Cases” at the SFF x SWITCH event, Mr. Tian Feng, Dean of Intelligent Industry Research Institute, SenseTime, said, “As AI technology immerses into our everyday lives, people may be exposed to the emergence of new risks. The launch of these two reports demonstrates our commitment to educate both the industry and the public at large, on how the technology can be harnessed ethically. We will continue developing AI technology that advances economies, society and humanity, tackle global challenges as well as The United Nations Sustainable Development Goals (SDGs) such as the COVID-19 pandemic and climate change.”

SFF x SWITCH is week-long festival for the global innovation community, featuring exciting innovation and technology activities. During the conference, SWITCH and Artificial Intelligence International Institute (AIII) co-hosted the “China Singapore Technovation Ecosystem Summit”, bringing together key players for more sharing and dialogue to foster more sustainable development and collaboration, where SenseTime unveiled its “AI Ethics for Balanced Development” report and “Best Practice Cases”.

Three fundamental principles to make AI fair, safe, controllable

With the rapid development of the technology, AI companies have a responsibility to work with different sectors of the community to monitor, govern and improve potential ethical risks. Over the past few years, SenseTime has been committed to promoting the progress of AI governance. Its whitepaper “Code of Ethics for Sustainable AI Development”, which laid down the foundation for its AI ethics discourse, was selected by the United Nations as one of the key publication references in its “United Nations Resource Guide on AI Strategies”.

To align with the development of the technology since its first whitepaper, SenseTime has refined its three core ethical principles for responsible AI in the latest “AI Ethics for Balanced Development” report, which calls on institutions, enterprises and individuals to respect and recognise the balance between innovation and ethics:

  1. Sustainability:

    AI can play an important role augmenting global efforts to address climate change and other sustainability challenges. The United Nations has introduced the 2030 Agenda for Sustainable Development with a global framework to achieve sustainable development in three dimensions – economic, social and environmental – by 2030. As technology continues to evolve, people have realized that AI can play a pivotal role in achieving the Sustainable Development Goals and benefit society.

    SenseTime’s AI technology is widely adopted by infrastructure companies to promote energy efficiency and clean energy. For example, China Southern Power Grid, one of two major power grids in the country, harnesses SenseTime’s SenseMARS solution to review its load forecasting. The application of AI in power grids empowers its operators to better optimise temperature and energy efficiency. This is one example of how AI can contribute to the Sustainable Development Goals, by supporting affordable, reliable and sustainable energy supply. 

  2. Human-Centric Approach:

    The purpose of AI is to augment humans and create new value. A broad range of factors such as human rights, privacy protection, inclusiveness and openness must be considered before applying the technology. SenseTime believes that the benefits brought by AI technology must be shared with everyone and must not be limited to select communities or groups. It strives to promote the practice of this approach in various fields to fulfil its social responsibility as a leader in the AI industry, vision and mission.

    In July 2021, SenseTime established a mixed reality (MR) virtual experience center at BilibiliWorld 2021. With the rise of the “metaverse” concept, SenseTime is well-placed to realise its potential through its proprietary AI+MR technology. By creating an extensive and diversified holographic digital world, SenseTime is set to open infinite opportunities for innovation in offline animation exhibitions and interactive entertainment.

  3. Controllable Technology:

    Safeguarding data and promoting trusted use has become a common goal for all technology companies. Key attributes such as verifiability, certification, creditability and responsibility must be in place to ensure adequate levels of safety to build trust; relevant regulation must be founded upon controllable technology to uphold AI ethics.

    SenseTime has been actively promoting the importance of protecting privacy in the use of AI technology. In 2020, SenseTime published a research paper with the Center for Computational Biomedicine Imaging and Modelling in the Computer Science Department at Rutgers University–New Brunswick at the European Conference on Computer Vision (ECCV), in which the structure of a distributed generative adversarial network (GAN) was adopted to achieve federated learning. By using a distributed asynchronized discriminator GAN with a GAN formed by a central generator, this research allows a central generator to function under which no private data are provided. This set of research methods inherited the strengths of federated learning and effectively solved the problem of privacy protection in medical data.

Robust internal initiatives to reinforce AI ethics efforts

In adherence with the three core ethical principles of responsible AI, SenseTime has implemented a number of initiatives in aspects of its operations. In January 2020, it established the Committee of AI Ethics and Governance, which comprises six members, including two external advisors, who are academic experts in the field of AI ethics, and four senior management members. As the company’s primary organization at the ethical level, the AI Ethics Committee is mainly responsible for AI ethics-related responsibilities, including principle formulation, concept publicity, and promoting the implementation of AI ethics measures, and determining SenseTime’s goals, policies, work guidance and implementation measures concerning AI ethics.

SenseTime also collaborates with third-party institutions and think tanks from around the world to keep abreast of the latest developments in the AI industry, and to maintain neutrality and objectivity in the implementation of its AI ethics practice.

Sustainability is a never-ending goal, and it will always be a fundamental strategy for SenseTime as it expands and diversifies its technology offerings. Together with partners, SenseTime will continue to work to promote fair, responsible, and legally complaint applications of AI technology.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

2 weeks ago

on

April 5, 2024

By

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

2 weeks ago

on

April 5, 2024

By

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

2 weeks ago

on

April 5, 2024

By

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading
Advertisement
Advertisement

Latest news

Trending